Solid-phase synthesis and biological evaluation of piperazine-based novel bacterial topoisomerase inhibitors
Research output: Contribution to journal › Journal article › peer-review
Documents
- Full text
Final published version, 747 KB, PDF document
There is an emerging global need for new and more effective antibiotics against multi-resistant bacteria. This situation has led to massive industrial investigations on novel bacterial topoisomerase inhibitors (NBTIs) that target the vital bacterial enzymes DNA gyrase and topoisomerase IV. However, several of the NBTI compound classes have been associated with inhibition of the hERG potassium channel, an undesired cause of cardiac arrhythmia, which challenges medicinal chemistry efforts through lengthy synthetic routes. We herein present a solid-phase strategy that rapidly facilitates the chemical synthesis of a promising new class of NBTIs. A proof-of-concept library was synthesized with the ability to modulate both hERG affinity and antibacterial activity through scaffold substitutions.
Original language | English |
---|---|
Article number | 128499 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 57 |
ISSN | 0960-894X |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Publisher Copyright:
© 2021 The Authors
- Antibiotics, Bacterial Topoisomerase Inhibitors (NBTIs), hERG potassium channel, SAR study, Solid-phase synthesis
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 288714419